Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-12-28
2000-03-21
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514183, 514210, 514255, 514318, 514326, 514332, 514333, 514336, 514340, 514341, 514342, 514343, 514374, 514376, 514381, 514383, 514397, 514401, 514422, 514331, A61K 31445
Patent
active
060403179
ABSTRACT:
A series of non-peptide derivatives that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet anti-aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.
REFERENCES:
patent: 4992463 (1991-02-01), Tjoeng et al.
patent: 4996050 (1991-02-01), Tsukada et al.
patent: 5053393 (1991-10-01), Tjoeng et al.
patent: 5174994 (1992-12-01), Collen
patent: 5814643 (1998-09-01), Duggan et al.
Duggan Mark E.
Egbertson Melissa S.
Halczenko Wasyl
Hartman George D.
Laswell William L.
Merck & Co. , Inc.
Parr Richard S.
Reamer James H.
Winokur Melvin
LandOfFree
Sulfonamide fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonamide fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamide fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-730586